BSI PD ISO/TR 12885:2018 – TC:2020 Edition
$280.87
Tracked Changes. Nanotechnologies. Health and safety practices in occupational settings
| Published By | Publication Date | Number of Pages |
| BSI | 2020 | 330 |
PDF Catalog
| PDF Pages | PDF Title |
|---|---|
| 196 | undefined |
| 201 | Foreword |
| 202 | Introduction |
| 205 | 1 Scope 2 Normative references 3 Terms and definitions 4 Symbols and abbreviated terms |
| 207 | 5 Nanomaterials: Description and manufacturing 5.1 Manufactured nanomaterials |
| 209 | 5.2 Production processes 5.2.1 Typical production processes 5.2.2 Aerosol generation methods 5.2.3 Vapor deposition methods 5.2.4 Colloidal/self-assembly methods |
| 210 | 5.2.5 Electrodeposition 5.2.6 Electrospinning 5.2.7 Attrition methods 6 Hazard characterization 6.1 Health effects 6.1.1 General |
| 211 | 6.1.2 Basic principles and uncertainties |
| 212 | 6.1.3 Potential relevance of health effects information about incidental or naturally-occurring NOAAs 6.1.4 Relationship between toxicity and surface area, surface chemistry, and particle number |
| 213 | 6.1.5 Inflammatory response to NOAAs 6.1.6 Observations from epidemiological studies involving fine and nanoscale particles |
| 214 | 6.2 Physical hazards 6.2.1 Fire (exothermic events) 6.2.2 Safety consideration in manufacturing NOAAs 7 Exposure assessment to nanomaterials 7.1 General |
| 216 | 7.2 Scientific framework for assessing exposure to nanomaterials 7.2.1 Routes of exposure |
| 218 | 7.2.2 Metric for assessing exposure to airborne nanomaterials |
| 221 | 7.3 Review of methods for characterizing exposure to manufactured NOAAs 7.3.1 General |
| 224 | 7.3.2 Sampling strategy issues |
| 228 | 7.4 Dustiness assessment 7.4.1 General 7.4.2 Measurement methods |
| 229 | 7.5 Dermal exposure assessment 7.5.1 Sampling |
| 230 | 7.5.2 Sample characterization 7.6 Dose (internal exposure) assessment 7.7 Discussion |
| 231 | 7.8 Summary 8 Risk assessment in occupational settings 8.1 Introduction and scope |
| 232 | 8.2 Risk assessment for NOAAs 8.2.1 General 8.2.2 Quantitative and qualitative risk assessment |
| 233 | 8.2.3 Hazard identification 8.2.4 Exposure-response assessment |
| 235 | 8.2.5 Exposure assessment |
| 236 | 8.2.6 Risk characterization 8.3 Conclusions 9 Risk mitigation approaches 9.1 Introduction |
| 237 | 9.2 Implication of risk assessment in regard to control methodologies 9.2.1 Background |
| 238 | 9.2.2 Strategies for control |
| 239 | 9.3 Examination of control methodologies 9.3.1 Exposure prevention |
| 240 | 9.3.2 Control strategies 9.3.3 Reducing risk through effective design |
| 241 | 9.3.4 Substitution of raw materials, products, processes and equipment 9.3.5 Engineering control techniques |
| 248 | 9.3.6 Administrative means for the control of workplace exposures |
| 253 | 9.3.7 Evaluating the work environment |
| 254 | 9.3.8 Personal protective equipment (PPE) |
| 259 | 9.4 Health surveillance |
| 260 | 9.5 Product stewardship |
| 262 | Annex A (informative) Primary chemical composition of nanomaterials |
| 270 | Annex B (informative) Nanomaterial-specific animal and cell culture toxicity studies |
| 282 | Annex C (informative) Characteristics of selected instruments and techniques for monitoring nano-aerosol exposure |
| 291 | Annex D (informative) Characteristics of biosafety cabinets |
| 293 | Annex E (informative) Assigned protection factors for respirators |
| 294 | Annex F (informative) Advantages and disadvantages of different types of air-purifying particulate respirators |
| 297 | Bibliography |
